ADVANCED ENERGY INDUSTRIES INC
For the period ended Mar 31, 2026. Filed May 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
NOTE 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
Advanced Energy Industries, Inc., a Delaware corporation, and its consolidated subsidiaries (“we,” “us,” “our,” or “Advanced Energy”) provides highly engineered, critical, precision power conversion, measurement, and control solutions to our global customers. We design, manufacture, sell, and service precision power products that transform, refine, and modify the raw electrical power coming from either the utility or the building facility and convert it into various types of highly controllable, usable power that is predictable, repeatable, and customizable to meet the necessary requirements for powering a wide range of complex equipment. Many of our products enable customers to reduce or optimize their energy consumption through increased power conversion efficiency, power density, power coupling, and process control across a wide range of applications.
In management’s opinion, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly Advanced Energy’s financial position as of March 31, 2026, and the results of our operations and cash flows for the three months ended March 31, 2026 and 2025.
The unaudited consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been omitted pursuant to such rules and regulations. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2025 and other financial information filed with the SEC.
Use of Estimates in the Preparation of the Consolidated Financial Statements
The preparation of our consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, assumptions, and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. The significant estimates, assumptions, and judgments include, but are not limited to, excess and obsolete inventory, income taxes and other provisions, and acquisitions and asset valuations.
Significant Accounting Policies
Our accounting policies are described inNote 1. Summary of Operations and Significant Accounting Policies and Estimates to our audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2025.
New Accounting Standards
From time to time, the Financial Accounting Standards Board (“FASB”) or other standards setting bodies issue new accounting pronouncements. Updates to the FASB Accounting Standards Codification (“ASC”) are communicated through issuance of an Accounting Standards Update (“ASU”). Unless otherwise discussed, we believe that the impact of recently issued guidance, whether adopted or to be adopted in the future, will not have a material impact on the consolidated financial statements upon adoption.
New Accounting Standards Adopted
In July 2025, the FASB issued ASU 2025-05*“Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets.”*ASU 2025-05 permits the use of certain estimates and assumptions in developing forecasts used for determining expected credit losses on accounts receivable. We adopted this guidance on January 1, 2026, and it was not material to our consolidated financial statements.
New Accounting Standards Issued But Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03*“**Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.”*ASU 2024-03 requires disaggregated disclosure of income statement expenses for public business entities. The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. This guidance will be effective for us on January 1, 2027. We do not expect the above guidance to materially impact our consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06*“Intangibles – Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.”*ASU 2025-06 eliminates the consideration of project development stages in determining whether a cost is eligible for capitalization. Instead, cost capitalization will be based on a “probable to complete” threshold. This guidance will be effective for us on January 1, 2028. We are evaluating the impact, if any, that the adoption of ASU 2025-06 may have on our consolidated financial statements.
NOTE 2. REVENUE
Disaggregation of revenue
The following tables present additional information regarding our revenue:
Revenue by Market
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2026 · · 2025 · | |||||||
| · · (in millions) | |||||||
| Semiconductor Equipment | | $219.4 | | $222.2 | | ||
| Data Center Computing | | | 194.2 | | | 96.2 | |
| Industrial and Medical | | 72.0 | | 64.3 | | ||
| Telecom and Networking | | | 25.4 | | | 21.9 | |
| Total | | $511.0 | | $404.6 | | ||
Revenue by Significant Countries
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | ||||||||||||
| · · 2026 · · · 2025 · | ||||||||||||
| · · (in millions) | ||||||||||||
| United States | | $142.5 | | 27.9% | | $144.2 | | 35.7% | ||||
| Mexico | | | 133.0 | | 26.0 | | | | 41.7 | | 10.3 | |
| All others | | | 235.5 | | 46.1 | | | | 218.7 | | 54.0 | |
| Total | | $511.0 | | 100.0% | | $404.6 | | 100.0% | ||||
We attribute revenue to individual countries based on the customer’s ship to location. Excluding the specific countries listed above, no individual country exceeded 10% of our total consolidated revenues during the periods presented.
Revenue by Category
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2026 · · 2025 · | |||||||
| · · (in millions) | |||||||
| Product | | $465.3 | | $360.2 | | ||
| Services and other | | | 45.7 | | 44.4 | | |
| Total | | $511.0 | $404.6 | | |||
Other revenue includes certain spare parts and products sold by our service group.
NOTE 3. BALANCE SHEET INFORMATION
Accounts Receivable, Net
We record accounts receivable at net realizable value. Our accounts receivable, net balance on the Consolidated Balance Sheets was $376.7 million as of March 31, 2026. As of March 31, 2026 and December 31, 2025, expected credit losses related to receivables were $0.7 million and $0.6 million, respectively.
Inventories
We value inventories at the lower of cost or net realizable value, computed on a first-in, first-out basis. Components of inventories were as follows:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| | | March 31, | | December 31, | |
| | | 2026 | | 2025 | |
| · · (in millions) · | |||||
| Parts and raw materials | | $362.7 | | $313.6 | |
| Work in process | | 31.5 | | 27.3 | |
| Finished goods | | 64.5 | | 70.3 | |
| Total | | $458.7 | | $411.2 | |
Warranties
Our sales agreements include customary product warranty provisions, which generally range from 12 to 36 months after shipment. We record the estimated warranty obligations cost when we recognize revenue. This estimate is based on historical experience by product and configuration.
Our estimated warranty obligation is included in other accrued expenses in our Consolidated Balance Sheets. Changes in our product warranty obligation were as follows:
| · · · | ||
|---|---|---|
| | | (in millions) |
| December 31, 2025 | | $7.2 |
| Warranty expenditures | | (0.4) |
| March 31, 2026 | | $6.8 |
NOTE 4. INTANGIBLE ASSETS AND GOODWILL
Intangible assets consisted of the following:
| | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| · · March 31, 2026 | |||||||||||
| · · Gross Carrying · · Accumulated · · Net Carrying · · Weighted-Average Remaining | |||||||||||
| · · Amount · · Amortization · · Amount · Useful Life (in years) | |||||||||||
| · · (in millions) · · | |||||||||||
| Technology | | $101.5 | | $(79.3) | | $22.2 | | 6.5 | |||
| Customer relationships | | 171.2 | | | (89.3) | | 81.9 | | 7.5 | ||
| Trademarks and other | | 27.2 | | | (18.9) | | 8.3 | | 3.4 | ||
| Total | | $299.9 | | $(187.5) | | $112.4 | | 7.0 | |||
| | | | | | | | | | | | |
| | | December 31, 2025 | |||||||||
| | | Gross Carrying | | Accumulated | | Net Carrying | | Weighted-Average Remaining | |||
| | | Amount | | Amortization | | Amount | | Useful Life (in years) | |||
| | | (in millions) | | | |||||||
| Technology | | $101.8 | | $(78.2) | | $23.6 | | 6.6 | |||
| Customer relationships | | 171.4 | | | (86.3) | | 85.1 | | 7.7 | ||
| Trademarks and other | | 27.3 | | | (18.3) | | 9.0 | | 3.6 | ||
| Total | | $300.5 | | $(182.8) | | $117.7 | | 7.2 | |||
Amortization expense related to intangible assets is as follows:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||
| | | 2026 | | 2025 | |
| · · (in millions) | |||||
| Amortization expense | | $5.3 | | $5.5 | |
Estimated future amortization expense related to intangibles is as follows:
| | | | |
|---|---|---|---|
| Year Ending December 31, | | | (in millions) |
| 2026 (remaining) | | $14.8 | |
| 2027 | | 17.8 | |
| 2028 | | 16.6 | |
| 2029 | | 15.0 | |
| 2030 | | | 13.4 |
| Thereafter | | 34.8 | |
| Total | | $112.4 |
The following table summarizes the changes in goodwill:
| | | | |
|---|---|---|---|
| · · (in millions) | |||
| December 31, 2025 | | $300.8 | |
| Foreign currency translation and other | | | (0.6) |
| March 31, 2026 | | $300.2 | |
NOTE 5. LEASES
Components of total operating lease cost were as follows:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2026 · · 2025 · | |||||||
| · · (in millions) | |||||||
| Operating lease cost | | $6.6 | | $6.5 | | ||
| Short-term and variable lease cost | | | 1.7 | | | 1.4 | |
| Total operating lease cost | | $8.3 | | $7.9 | | ||
Estimated future payments on our operating lease liabilities are as follows:
| | | | |
|---|---|---|---|
| Year Ending December 31, | | | (in millions) |
| 2026 (remaining) | | $17.4 | |
| 2027 | | 22.2 | |
| 2028 | | 21.9 | |
| 2029 | | | 18.2 |
| 2030 | | | 16.7 |
| Thereafter | | | 58.4 |
| Total lease payments | | | 154.8 |
| Less: Interest | | | (39.9) |
| Present value of lease liabilities | | $114.9 |
In addition to the above, we have a lease agreement with total payments of $8.9 million that commences in the third quarter of 2026 and extends through 2031.
The following tables present additional information about our lease agreements:
| | | | | | | | | |
|---|---|---|---|---|---|---|---|---|
| · · March 31, · · · December 31, · | ||||||||
| · · 2026 · · · 2025 · | ||||||||
| Weighted-average remaining lease term (in years) | | | 8.1 | | | | 8.2 | |
| Weighted-average discount rate | | 6.3% | | | 6.4% | |||
| · · · · · · | ||||
|---|---|---|---|---|
| · Three Months Ended March 31, · | ||||
| | 2026 | | 2025 | |
| · (in millions) | ||||
| Cash paid for operating leases | $6.9 | | $6.3 | |
| Right-of-use assets obtained in exchange for operating lease liabilities | $8.4 | | $12.3 | |
NOTE6. LONG-TERM DEBT
Long-term debt on our Consolidated Balance Sheets consists of the following:
| | | | | | | |
|---|---|---|---|---|---|---|
| · · March 31, · · December 31, | ||||||
| · · 2026 · · 2025 | ||||||
| · · (in millions) | ||||||
| Convertible Notes due 2028, 2.5% interest | | $575.0 | | $575.0 | ||
| Less: debt discount | | | (6.8) | | | (7.5) |
| Net long-term debt | | | 568.2 | | | 567.5 |
| Less: current maturities | | | (568.2) | | | (567.5) |
| Net long-term debt | | $— | | $— | ||
As of March 31, 2026, we were in compliance with the covenants under all debt agreements.
The following table summarizes interest expense related to our debt:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2026 · · 2025 · | |||||||
| · · (in millions) | |||||||
| Interest expense | | $3.6 | | $3.5 | | ||
| Amortization of debt issuance costs | | | 0.8 | | | 0.7 | |
| Total interest expense related to debt | | $4.4 | | $4.2 | | ||
Credit Agreement
On May 8, 2025, we terminated our prior credit agreement, dated as of September 10, 2019 (and subsequently amended) and entered into a new credit agreement (the “Credit Agreement”) consisting of a senior unsecured term loan facility (“Term Loan Facility”) and a senior unsecured revolving facility (“Revolving Facility”), both maturing on May 8, 2030. The maturity date may be accelerated to the date that is 91 days prior to the maturity date of our $575.0 million aggregate principal amount of 2.50% convertible senior notes due September 15, 2028 (the “Convertible Notes”), if the sum of our consolidated cash and cash equivalents plus the undrawn balance on the Revolving Facility is less than 120% of the redemption amount of the Convertible Notes.
The financing terms of the new Credit Agreement are substantially the same as the terms of the prior credit agreement. As part of the new credit facility, HSBC Bank USA, N.A. (“HSBC”) was appointed as the administrative agent for the lender group.
At the time of termination, no borrowings were outstanding under the prior credit agreement, and there have beenno borrowings under the Credit Agreement to date. As of March 31, 2026, we had $600.0 million available on the Revolving Facility.
In addition to our available capacity on the Revolving Facility, prior to the maturity date of the Credit Agreement, we may request an increase to the financing commitments in either the Term Loan Facility or Revolving Facility by an aggregate amount not to exceed $250.0 million. Any requested increase is subject to lender approval.
Should we have future borrowings under the Term Loan Facility or Revolving Facility, they will bear interest, at our option, at a rate based on the Base Rate or SOFR, as defined in the Credit Agreement, plus an applicable margin.
Convertible Senior Notes due 2028
On September 12, 2023, we completed a private, unregistered offering of the Convertible Notes.
The remaining outstanding principal amount of the Convertible Notes, amounting to $568.2 million, net of unamortized issuance costs, was classified as current as of March 31, 2026. Pursuant to the indenture governing the Convertible Notes, because the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on March 31, 2026 was greater than or equal to $179.76 on each applicable trading day, the holders have the right to surrender any portion of their Convertible Notes (in minimum denominations of $1,000 in principal amount or an integral multiple thereof) for conversion during the calendar quarter ending June 30, 2026, and only during such calendar quarter. We reassess the classification of the Convertible Notes at each quarterly reporting period, considering the trading price of our common stock relative to the conversion criteria. The redemption price is 100% of the principal amount plus accrued and unpaid interest.
The Convertible Notes mature on September 15, 2028, unless earlier repurchased, redeemed, or converted. Interest is payable semi-annually in arrears in March and September. Exclusive of any early conversion elections by the convertible noteholders, there are no scheduled debt maturities until 2028.We do not maintain a sinking fund.
Concurrent with the Convertible Notes issuance, we entered into hedges (“Note Hedges”) with respect to our common stock and sold warrants to purchase our common stock (“Warrants”). In combination, the Note Hedges and Warrants synthetically increase the initial conversion price on the Convertible Notes from$137.46 to$179.76, reducing the potential dilutive effect.
We use level 2 measurements to estimate the fair value of our debt. As of March 31, 2026 and December 31, 2025, we estimate the fair value of our Convertible Notes to be $1.3 billion and $951.1 million, respectively.
NOTE 7.STOCKHOLDERS’ EQUITY AND EARNINGS PER SHARE
Accumulated Other Comprehensive Income (Loss)
The following table summarizes the components of, and changes in, accumulated other comprehensive income
(loss), net of income taxes.
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| | | | Foreign Currency Translation | | | Defined Employee Benefit Plan | | | Total |
| · · (in millions) | |||||||||
| Balance at December 31, 2024 | | $(22.3) | | $10.5 | | $(11.8) | |||
| Other comprehensive income (loss) prior to reclassifications | | | 4.5 | | | — | | | 4.5 |
| Amounts reclassified from accumulated other comprehensive income (loss) | | | 0.1 | | | (0.1) | | | — |
| Balance at March 31, 2025 | | $(17.7) | | $10.4 | | $(7.3) | |||
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| | | | Foreign Currency Translation | | | Defined Employee Benefit Plan | | | Total |
| · · (in millions) | |||||||||
| Balance at December 31, 2025 | | $(7.1) | | $13.3 | | $6.2 | |||
| Other comprehensive income (loss) prior to reclassifications | | | (3.2) | | | — | | | (3.2) |
| Amounts reclassified from accumulated other comprehensive income (loss) | | | — | | | (0.1) | | | (0.1) |
| Balance at March 31, 2026 | | $(10.3) | | $13.2 | | $2.9 | |||
Amounts reclassified from accumulated other comprehensive income (loss) to the specific caption within the
Consolidated Statements of Operations were as follows:
| | | | | | | | | |
|---|---|---|---|---|---|---|---|---|
| · Three Months Ended March 31, · · · To Caption on Consolidated | ||||||||
| · 2026 · · 2025 · · · Statements of Operations | ||||||||
| · (in millions) · · · | ||||||||
| Foreign currency translation | $— | | $(0.1) | | | Other expense, net | ||
| Defined employee benefit plan | | 0.1 | | | 0.1 | | | Other expense, net |
| Total reclassifications | $0.1 | | $— | | | | ||
Earnings Per Share
The following table summarizes our earnings per share (“EPS”):
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2026 · · 2025 · | |||||||
| · · (in millions, except per share amounts) | |||||||
| Income from continuing operations | | $67.3 | | $24.9 | | ||
| | | | | | | | |
| | | | | | | | |
| Basic weighted-average common shares outstanding | | 37.7 | | 37.6 | | ||
| Dilutive effect of Convertible Notes | | | 2.2 | | | — | |
| Dilutive effect of Warrants | | | 1.6 | | | — | |
| Dilutive effect of stock awards | | 0.7 | | 0.5 | | ||
| Diluted weighted-average common shares outstanding | | 42.2 | | 38.1 | | ||
| | | | | | | | |
| | | | | | | | |
| EPS from continuing operations | | | | | | ||
| Basic EPS | | $1.79 | | $0.66 | | ||
| Diluted EPS | | $1.59 | | $0.65 | | ||
| | | | | | | | |
| | | | | | | | |
| Anti-dilutive shares not included above | | | | | | | |
| Warrants | | | — | | | 2.4 | |
We compute basic earnings per share of common stock (“Basic EPS”) by dividing income available to common stockholders by the weighted-average number of common shares outstanding during the period.
SeeNote 7. Long-Term Debtin our Annual Report on Form 10-K for the year ended December 31, 2025 for information regarding our Convertible Notes, Note Hedges, and Warrants. For diluted earnings per share of common
stock (“Diluted EPS”), we increase the weighted-average number of common shares outstanding during the period, as needed, to include the following:
| ● | Additional common shares that would have been outstanding if our outstanding stock awards had been converted to common shares using the treasury stock method. We exclude any stock awards that have an anti-dilutive effect; |
| ● | Dilutive impact associated with the Convertible Notes using the if-converted method. The Convertible Notes are repayable in cash up to par value and in cash or shares of common stock for the excess over par value. When the stock price is lower than the strike price, there is no dilutive or anti-dilutive impact. When the stock price is higher than the initial strike price, there is a dilutive impact associated with the Convertible Notes. Prior to conversion, we do not consider the Note Hedges for purposes of Diluted EPS as their effect would be anti-dilutive. Upon conversion, we expect the Note Hedges to offset the dilutive effect of the Convertible Notes when the stock price is above $137.46 but below $179.76; and |
| ● | Dilutive effect of the Warrants issued concurrently with the Convertible Notes using the treasury stock method. For all periods presented, the Warrants increased the weighted-average number of common shares outstanding because the average market price of our common stock exceeded the $179.76 exercise price of the Warrants. |
Share Repurchases
To repurchase shares of our common stock, we periodically enter into share repurchase agreements. The following table summarizes these repurchases:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||
| | | 2026 | | 2025 | |
| · · (in millions, except share and per share amounts) | |||||
| Amount paid or accrued to repurchase shares | | $0.3 | | $0.9 | |
| Number of shares repurchased | | 1,500 | | 9,636 | |
| Average repurchase price per share | | $209.36 | | $94.26 | |
There wereno share repurchases from related parties during the three months ended March 31, 2026.
As of March 31, 2026, the remaining amount authorized by the Board of Directors (“our Board” or “the Board”) for future share repurchases was$166.6 million with no time limitation.
NOTE 8. FAIR VALUE MEASUREMENTS
The following tables present information about our non-pension assets and liabilities measured at fair value on a recurring basis. We classify all items below within level 2 of the fair value hierarchy. SeeNote 6. Long-Term Debt for information regarding the fair value of our Convertible Notes.
| · · · · · · · · | ||||||
|---|---|---|---|---|---|---|
| | | | | March 31, | | December 31, |
| | | | | 2026 | | 2025 |
| Description · · Balance Sheet Classification · · (in millions) | ||||||
| Certificates of deposit | | Other current assets | | $0.2 | | $0.2 |
| Foreign currency forward contracts | | Other accrued expenses | | $0.1 | | $0.1 |
| Investments | | Other assets | | $17.3 | | $13.5 |
| Deferred compensation liabilities | | Other liabilities | | $17.7 | | $13.4 |
NOTE 9. DERIVATIVE FINANCIAL INSTRUMENTS
Changes in foreign currency exchange rates impact our results of operations and cash flows. We may manage these risks through the use of derivative financial instruments, primarily forward contracts with banks. These forward contracts manage the exchange rate risk associated with assets and liabilities denominated in nonfunctional currencies. Typically, we execute these derivative instruments for one-month periods and do not designate them as hedges for accounting purposes; however, they do partially offset the economic fluctuations of certain of our assets and liabilities due to foreign exchange rate changes. The gains and losses related to these foreign currency exchange contracts are intended to offset the corresponding gains and losses on the revaluation of the underlying assets and liabilities. Both are included as a component of other expense, net in our Consolidated Statements of Operations.
As of March 31, 2026 and December 31, 2025, we had $73.2 million and $60.5 million, respectively, of foreign currency forward contracts outstanding.
SeeNote 8. Fair Value Measurements for information regarding fair value of derivative instruments.
As a result of using derivative financial instruments, we are exposed to the risk that counterparties to contracts could fail to meet their contractual obligations. We manage this credit risk by reviewing counterparty creditworthiness on a regular basis and limiting exposure to any single counterparty.
NOTE 10. RESTRUCTURING, ASSET IMPAIRMENTS, AND OTHER CHARGES
Details of restructuring, asset impairments, and other charges are as follows:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2026 · · 2025 · | |||||||
| · · (in millions) | |||||||
| Restructuring | | $2.0 | | $0.6 | | ||
| Other charges | | | 0.6 | | | 0.6 | |
| Total restructuring, asset impairments, and other charges | | $2.6 | $1.2 | ||||
Restructuring
We have the following restructuring plans in process. The amounts incurred as a result of the approved actions are estimates, and actual results may differ, which could result in incremental restructuring charges in future periods.
2026 Plan
In 2026, we reorganized our Global Sales, Marketing and Operations team to meet our current and future needs including geographic needs (the “2026 Plan”). We expect these activities to conclude in 2026 and do not expect to incur significant additional charges.
2025 Plan
During the second quarter of 2025, we approved actions related to consolidating our research and development, sales, and administrative functions in connection with our manufacturing and footprint consolidation (the “2025 Plan”). We expect these actions to be substantially complete during 2027 and do not expect to incur significant additional charges.
2024 Plan
In 2024, we approved actions in furtherance of our manufacturing consolidation initiatives intended to optimize our manufacturing footprint and cost structure, including the closure of our Zhongshan, China manufacturing facility (the “2024 Plan”). Manufacturing operations in Zhongshan ceased during the second quarter of 2025. Final closure activities are in progress and expected to conclude in 2026. During the quarter, we recognized expenses of $0.5 million related to these actions and may incur additional charges to complete the closure.
2023 Plan
In 2023, we approved a plan intended to optimize and further consolidate our manufacturing operations and functional support groups as well as a general reduction-in-force to align our expenses to revenue levels (the “2023 Plan”). We expect final activities to conclude in the first quarter of 2027 and do not expect to incur significant additional charges.
Changes in restructuring liabilities were as follows:
| | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · 2026 Plan · · 2025 Plan · · 2024 Plan · · 2023 Plan · · Total | |||||||||||||||
| · · (in millions) | |||||||||||||||
| December 31, 2025 | | $— | | $4.5 | | $3.4 | | $3.2 | | $11.1 | |||||
| Costs incurred and charged to expense | | | 1.4 | | | — | | | 0.5 | | | 0.1 | | | 2.0 |
| Costs paid | | | — | | | (0.2) | | | (1.4) | | | (0.5) | | | (2.1) |
| March 31, 2026 | | $1.4 | | $4.3 | | $2.5 | | $2.8 | | $11.0 | |||||
The above restructuring liability of $11.0 million is comprised of $6.6 million in other accrued expenses and $4.4 million in other long-term liabilities on our Consolidated Balance Sheets.
| | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Cumulative Cost Through | |||||||||||||||
| · · March 31, 2026 | |||||||||||||||
| · · 2026 Plan · · · 2025 Plan · · 2024 Plan · · 2023 Plan · · Total | |||||||||||||||
| · · (in millions) | |||||||||||||||
| Severance and related charges | | $1.4 | | $4.7 | | $31.2 | | $16.0 | | $53.3 | |||||
| Facility relocation and closure charges | | | — | | | — | | | 0.1 | | | — | | | 0.1 |
| Total restructuring charges | | $1.4 | | $4.7 | | $31.3 | | $16.0 | | $53.4 | |||||
Other Charges
Other charges relate to personnel transition costs and costs related to organizational restructuring activities of our legal entities.
NOTE 11. STOCK-BASED COMPENSATION
The Compensation Committee of our Board administers our stock plans. As of March 31, 2026, we havetwo active stock-based incentive compensation plans: the Amended and Restated 2023 Omnibus Incentive Plan (the “2023 Incentive Plan”) and the Employee Stock Purchase Plan (“ESPP”). We issue all new equity compensation grants under the 2023 Incentive Plan. Outstanding awards previously issued under inactive plans will continue to vest and remain exercisable in accordance with the terms of the respective plans. We do not have material outstanding stock option awards.
The 2023 Incentive Plan provides for the grant of awards including stock options, stock appreciation rights, performance stock units, performance units, stock, restricted stock, restricted stock units, and cash incentive awards.
The following table summarizes information related to our stock-based incentive compensation plans:
| | | |
|---|---|---|
| | | March 31, 2026 |
| | | (in millions) |
| Shares available for future issuance under the 2023 Incentive Plan | | 1.2 |
| Shares available for future issuance under the ESPP | | 0.5 |
Stock-Based Compensation Expense
We recognize stock-based compensation expense based on the fair value of the awards issued and the functional area of the employee receiving the award. During the three months ended March 31, 2026, stock-based compensation expense included $0.9 million related to the acquisition of Airity Technologies, Inc. in June 2024. Stock-based compensation was as follows:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||
| | | 2026 | | 2025 | |
| · · (in millions) | |||||
| Stock-based compensation expense | | $18.1 | | $13.0 | |
Restricted Stock Units
Generally, we grant restricted stock units (“RSUs”) with athree-year time-based vesting schedule. Certain RSUs contain performance-based or market-based vesting conditions in addition to the time-based vesting requirements. RSUs are generally granted with a grant date fair value based on the market price of our stock on the date of grant. For RSUs that vest based on our relative total shareholder return over the performance period to a predetermined peer group, fair value is predetermined based on a Monte Carlo simulation as of the date of the grant.
Changes in our RSUs were as follows:
| · · · · · | |||
|---|---|---|---|
| · · Three Months Ended March 31, 2026 | |||
| · · · · Weighted- | |||
| · · · · Average | |||
| · · Number of · · Grant Date | |||
| · · RSUs · · Fair Value | |||
| · · (in millions) · · | |||
| RSUs outstanding at beginning of period | 1.0 | | $111.72 |
| RSUs granted | 0.3 | | $281.24 |
| RSUs vested | (0.4) | | $105.93 |
| RSUs forfeited | (0.1) | | $116.88 |
| RSUs outstanding at end of period | 0.8 | | $170.34 |
RSUs that vested during the period were higher than RSUs granted due to performance of our stock price.
Deferred Compensation Plan
We offer certain employees the opportunity to defer compensation and stock awards and maintain a rabbi trust in connection with this deferred compensation plan. Assets of the rabbi trust are consolidated as we are the primary beneficiary. Although we cannot use the rabbi trust’s assets for any purpose other than meeting our obligations under the deferred compensation plan, the trust’s assets, liabilities, and activity are included in our consolidated financial statements.
Assets of the rabbi trust not held in Company shares are presented in other assets, and the fair value of the Company shares held in the rabbi trust is classified in stockholders’ equity.
After a holding period, employees have the option to diversify the Company shares into other funds. Stock awards that have been elected for deferral but have not yet vested and are probable of vesting are reported as deferred compensation in the temporary equity section of the Consolidated Balance Sheets. The stock awards recorded in temporary equity are recognized at fair value, with any difference from stock-based compensation recorded in retained earnings.
The following table summarizes information regarding the rabbi trust’s assets and liabilities:
| · · · · · · | ||||
|---|---|---|---|---|
| | | March 31, | | December 31, |
| | | 2026 | | 2025 |
| Description · Balance Sheet Classification · (in millions) | ||||
| Investments | Other assets | $17.3 | | $13.5 |
| Deferred compensation liabilities | Other liabilities | $17.7 | | $13.4 |
| Stock awards elected for deferral | Temporary equity | $18.2 | | $7.8 |
| Company shares of common stock | Stockholders' equity | $14.8 | | $2.6 |
NOTE 12. INCOME TAX
The following table summarizes tax provision and the effective tax rate for our income from continuing operations:
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||
| | | 2026 | | 2025 | |
| · · (in millions) | |||||
| Income from continuing operations, before income tax | | $70.0 | | $29.9 | |
| Income tax provision | | $2.7 | | $5.0 | |
| Effective tax rate | | | 3.9% | | 16.7% |
Our effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the benefit of earnings in foreign jurisdictions which are subject to lower tax rates, as well as tax credits, partially offset by net U.S. tax on foreign operations. The effective tax rate as of March 31, 2026 is lower than the same period in 2025 primarily due to excess tax benefits recognized from stock-based compensation.
As of March 31, 2026, certain countries in which the Company operates have implemented or are in the process of implementing the Pillar II minimum global effective tax rate regime as put forth by the Organization for Economic Cooperation and Development (“OECD”). Specifically, the OECD released prospective “Side-by-Side” guidance in
early 2026 which is generally beneficial to U.S. parented organizations, but will require adoption by member countries to implement. As countries continue to make revisions to legislation and release additional guidance with respect to the global minimum tax, we continue to monitor and evaluate potential cash tax expense and associated impacts to the effective tax rate in the jurisdictions in which the Company operates.
On July 4, 2025, the One Big Beautiful Bill (“OBBB”) Act, which includes a broad range of elective tax law items available in 2025 and prescribed tax law changes in 2026, was signed into law in the United States. The Company has reflected the impact of the OBBB’s elective tax law items in its financial statements for the period ending March 31, 2026. The OBBB is expected to have an overall positive effect on the GAAP and non-GAAP effective tax rate of the Company, benefiting from revisions to foreign-derived intangible income (FDII) and the foreign tax credit rules.
NOTE 13. COMMITMENTS AND CONTINGENCIES
We are involved in disputes and legal actions arising in the normal course of our business. While we currently believe that the amount of any ultimate loss would not be material to our financial position, the outcome of these actions is inherently difficult to predict. In the event of an adverse outcome, the ultimate loss could have a material adverse effect on our financial position or reported results of operations. An unfavorable decision in intellectual property litigation also could require material changes in production processes and products or result in our inability to ship products or components found to have violated third party intellectual property rights. We accrue loss contingencies in connection with our commitments and contingencies, including litigation, when it is probable that a loss has occurred, and the amount of such loss can be reasonably estimated. We are not currently a party to any other legal action that we believe would have a material adverse impact on our business, financial condition, results of operations or cash flows.
NOTE 14. SUPPLEMENTAL CASH FLOW INFORMATION AND OTHER DISCLOSURES
Certain of our cash and non-cash activities were as follows:
| | | | | | | | |
|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, · | |||||||
| · · 2026 · · 2025 · | |||||||
| · · (in millions) · | |||||||
| Non-cash investing activities: · · · · · · | |||||||
| Capital expenditures in accounts payable and other accrued expenses | | $36.4 | | $14.6 | | ||
| Cash paid for: | | | | | | | |
| Interest | | $7.2 | | $7.2 | | ||
| Income taxes | | $4.8 | | $2.9 | | ||
| Cash received from income taxes | | $2.2 | | $1.1 | | ||
| Restricted cash (in Other current assets) | | $1.9 | | $ | - | | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.